Bob Hearn believes in making legal work count and never losing sight of every task’s value proposition. He uses creative but practical strategies to resolve disputes, manage liabilities, and untangle regulatory and compliance challenges in an efficient yet durable manner. That’s why clients trust him when complex and potentially costly matters require attention.
Bob’s practice, while legally diverse—covering both litigation and regulatory, compliance, and business counseling work—has a strong focus on the health care and life science sector. Bob has dedicated a significant part of his career to representing a national clinical laboratory in a wide array of litigation matters and in facility and personnel licensure and certification, billing, compliance, regulatory, and payor-oriented matters that span the lab’s operations. In addition to his deep experience with laboratories, Bob serves a broad range of health care and life sciences clients. Clinical research entities, pharmaceutical companies, medical product manufacturers, medical practices, and other health service providers also turn to Bob to defend them in products liability, death and injury, and commercial litigation and to advise them on risk mitigation and regulatory and compliance concerns.
Geographically, Bob litigates throughout Florida and in other jurisdictions across the country. Likewise, his regulatory work often engages him with state and local governments outside of Florida.
In court proceedings, Bob is known for investigating cases thoroughly, getting ahead of his opponents on the medicine and science, and distilling and presenting complex issues to courts and juries in an approachable way. His litigation experience allows him to bring sophisticated but practical regulatory counsel to his clients in the laboratory, clinical trial, pharmaceutical, and medical products industries.
Before joining Epstein Becker Green, Bob was a health care attorney and commercial litigator at a regional law firm. Earlier in his career, he was an associate, then a partner, at a prominent white collar defense firm and a law clerk to U.S. Magistrate Judge Mark A. Pizzo of the U.S. District Court for the Middle District of Florida.
More Legal and Business Bylines From Robert (Bob) R. Hearn
- BioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs - (Posted On Friday, March 08, 2024)
- Sponsored Genetic Testing Programs: Compliance Considerations Following DOJ False Claims Act Settlement - (Posted On Friday, January 19, 2024)
- Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] - (Posted On Thursday, September 28, 2023)
- Podcast: No Surprises Act: New Rules and Guidance for Stakeholders (Part 2) – Diagnosing Health Care - (Posted On Thursday, January 13, 2022)
- CMS Issues Guidance on COVID-19 Testing in the Workplace - (Posted On Thursday, December 16, 2021)
- New Guidance Clarifies Requirements for Onsite Workplace COVID-19 Testing - (Posted On Wednesday, December 15, 2021)
- Getting Ready for the No Surprises Act [VIDEO] - (Posted On Tuesday, November 23, 2021)
- Diagnosing Health Care - No Surprises Act: Considerations for Plans and Providers [PODCAST] - (Posted On Thursday, September 30, 2021)
- Florida Joins a Growing Number of States Requiring Licensure of Genetic Counselors - (Posted On Friday, August 06, 2021)
- Florida Legislature Provides COVID-19 Liability Protection for Health Care Providers - (Posted On Friday, April 09, 2021)